Regenerative Rehabilitation: Musculoskeletal Injuries
Our technology uses a closed cGMP system that resembles the physiological environment of MSCs in the human body, as well as an oxygen-controlled (hypoxia) and animal-free (xeno-free) environment, eliminating the risks of rejection and allergic reactions. These cells technologies release soluble biomolecules, such as cytokines, chemokines and growth factors, which act in a paracrine/endocrine manner to facilitate healing of damaged tissue by stimulating the body’s own regenerative mechanisms. CELLUS personalized cell products, are delivered through precise ultrasound guided injections for an accurate administration at the exact site of the injury.
Cellular Oncology: Skin Melanoma and Prostate Adenocarcinoma
The technology behind TapCells® is based on the generation of a self induced response by the host through the activation of the immune system. The production of TapCells® is generated from the own patient peripheral blood, from where an monocyte enriched cellular concentrated is obtained. This concentrate is cultivated under strict laboratory conditions and stimulated with cytokines along tumoral cell extract, this process generate TRIMEL®, which modify monocytes into tailored antigen presenting cells. After that, the modify monocytes are exposed to a cancer specific tumoral lysate, which will generate the markers which will allow a specific immune response against a specific kind of tumor.